US2014315757A1PendingUtilityA1
Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
Est. expiryMay 29, 2016(expired)· nominal 20-yr term from priority
C12Q 1/6813C12Q 2600/16C12Q 2600/156C12Q 1/6881C12Q 1/686C12Q 1/6876C12Q 1/6853C12Q 1/683C12Q 1/6827C12Q 1/6851C12Q 1/6858C12Q 1/6862C12Q 1/6869
79
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method for identifying a target nucleotide sequence. This method involves forming a ligation product on a target nucleotide sequence in a ligation detection reaction mixture, amplifying the ligation product to form an amplified ligation product in a polymerase chain reaction (PCR) mixture, detecting the amplified ligation product, and identifying the target nucleotide sequence. Such coupling of the ligase detection reaction and the polymerase chain reaction permits multiplex detection of nucleic acid sequence difference.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A kit for identifying a plurality of polymorphic loci comprising:
a plurality of oligonucleotide probe sets, each probe set comprising (i) a first allele-specific oligonucleotide probe comprising a first target allele-specific portion and a first 5′ upstream primer-specific portion, (ii) a second allele-specific oligonucleotide probe comprising a second target allele-specific portion and a second 5′ upstream primer-specific portion, and (iii) a common locus-specific oligonucleotide probe comprising a target specific portion and a 3′ downstream primer-specific portion; a ligase; and an oligonucleotide primer set comprising (i) a first upstream primer containing the same sequence as the first 5′ upstream primer-specific portion of the first allele-specific oligonucleotide probe, (ii) a second upstream primer containing the same sequence as the second 5′ upstream primer-specific portion of the second allele-specific oligonucleotide probe, and (iii) a downstream primer complementary to the 3′ downstream primer-specific portion of the common locus-specific oligonucleotide probe, wherein the first and the second upstream primers each comprise a different fluorescent label.
2 . The kit according to claim 1 , wherein the ligase is selected from the group consisting of Thermus aquaticus ligase, Thermus thermophilus ligase, E. coli ligase, T4 ligase, and Pyrococcus ligase.
3 . The kit according to claim 1 , wherein the target-allele specific portions of the oligonucleotide probes each have a hybridization temperature of 50-85° C.
4 . The kit according to claim 1 , wherein the target allele-specific portions of the oligonucleotide probe sets are 20-28 nucleotides long.
5 . The kit according to claim 1 , wherein the oligonucleotide probe sets are selected from the group consisting of ribonucleotides, deoxyribonucleotides, modified ribonucleotides, modified deoxyribonucleotides, modified phosphate-sugar backbone oligonucleotides, nucleotide analogues, and mixtures thereof.
6 . The kit according to claim 1 , wherein the oligonucleotide primer sets are selected from the group consisting of ribonucleotides, deoxyribonucleotides, modified ribonucleotides, modified deoxyribonucleotides, modified phosphate-sugar backbone oligonucleotides, nucleotide analogues, and mixtures thereof.
7 . The kit according to claim 1 , wherein the oligonucleotide probe sets each comprise a different addressable array-specific portion on one of oligonucleotide probes.
8 . The kit according to claim 7 further comprising:
a solid support with different capture oligonucleotides immobilized at different particular sites, wherein the capture oligonucleotides have nucleotide sequences complementary to the addressable array-specific portions.
9 . The kit according to claim 8 , wherein the capture oligonucleotides are selected from the group consisting of ribonucleotides and deoxyribonucleotides.
10 . The kit of claim 1 , wherein the common locus-specific oligonucleotide probe of each oligonucleotide probe set comprises a different addressable array-specific portion.
11 . The kit according to claim 10 further comprising:
a solid support with different capture oligonucleotides immobilized at different particular sites, wherein the capture oligonucleotides have nucleotide sequences complementary to the addressable array-specific portions.
12 . The kit according to claim 11 , wherein the capture oligonucleotides are selected from the group consisting of ribonucleotides, deoxyribonucleotides, modified ribonucleotides, modified deoxyribonucleotides, modified phosphate-sugar backbone oligonucleotides, nucleotide analogues, peptide nucleotide analogues, modified peptide nucleotide analogues, and mixtures thereof.
13 . The kit according to claim 1 , wherein each oligonucleotide primer set comprises a different addressable array-specific portion on one of the oligonucleotide primers.
14 . The kit according to claim 13 further comprising:
a solid support with different capture oligonucleotides immobilized at different particular sites, wherein the capture oligonucleotides have nucleotide sequences complementary to the addressable array-specific portions.
15 . The kit according to claim 14 , wherein the capture oligonucleotides are selected from the group consisting of ribonucleotides, deoxyribonucleotides, modified ribonucleotides, modified deoxyribonucleotides, modified phosphate-sugar backbone oligonucleotides, nucleotide analogues, peptide nucleotide analogues, modified peptide nucleotide analogues, and mixtures thereof.
16 . The kit according claim 1 further comprising:
uracil N-glycosylase.
17 . The kit according to claim 1 , wherein the first target allele-specific portion and the second target allele-specific portion of each oligonucleotide probe sets have an identical nucleotide sequence except for the nucleotide at the 3′ terminus of the allele-specific portion, and wherein the 3′ terminus of the allele-specific portion is the 3′ terminus of the oligonucleotide probe.
18 . The kit according to claim 17 , wherein, for each probe set of the plurality of probe sets, the 5′ upstream primer-specific portions have an identical nucleotide sequence and the 3′ downstream primer-specific portions have an identical nucleotide sequence.
19 . The kit according to claim 1 , wherein, for each probe set of the plurality of probe sets, the 5′ upstream primer-specific portions have an identical nucleotide sequence and the 3′ downstream primer-specific portion have an identical nucleotide sequence.
20 . A composition comprising two or more oligonucleotide probe sets for identifying two or more of a plurality of target polymorphic loci, each probe set comprising:
(i) a first allele-specific oligonucleotide probe comprising a first target allele-specific portion and a first 5′ upstream primer-specific portion, (ii) a second allele-specific oligonucleotide probe comprising a second target allele-specific portion and a second 5′ upstream primer-specific portion, and (iii) a common locus-specific oligonucleotide probe comprising a target specific portion and a 3′ downstream primer-specific portion.
21 . The compositions according to claim 20 , wherein the target-allele specific portions of the oligonucleotide probes each have a hybridization temperature of 50-85° C.
22 . The composition according to claim 20 , wherein the target allele-specific portions of the oligonucleotide probe sets are 20-28 nucleotides long.
23 . The composition according to claim 20 , wherein the oligonucleotide probe sets are selected from the group consisting of ribonucleotides, deoxyribonucleotides, modified ribonucleotides, modified deoxyribonucleotides, modified phosphate-sugar backbone oligonucleotides, nucleotide analogues, and mixtures thereof.
24 . The composition according to claim 20 , wherein the oligonucleotide probe sets comprise an addressable array-specific portion on one of oligonucleotide probes.
25 . The composition according to claim 24 further comprising:
a solid support with different capture oligonucleotides immobilized at different particular sites, wherein the capture oligonucleotides have nucleotide sequences complementary to the addressable array-specific portions.
26 . The composition according to claim 25 , wherein the capture oligonucleotides are selected from the group consisting of ribonucleotides, deoxyribonucleotides, modified ribonucleotides, modified deoxyribonucleotides, modified phosphate-sugar backbone oligonucleotides, nucleotide analogues, peptide nucleotide analogues, modified peptide nucleotide analogues, and mixtures thereof.Join the waitlist — get patent alerts
Track US2014315757A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.